🇺🇸 FDA
Company

Immix

Immix Biopharma

IMMX biotech USA

Quick answer

Immix is a biotech company (IMMX) headquartered in LOS ANGELES, CA, USA with 3 tracked pipeline programs.

Pipeline (3)

project

IMX-110 combined with Tislelizumab

Advanced Solid Tumor

Phase 2 · small_molecule · active

1 trials project

Imx-110

Solid Tumor, Adult

Phase 2 · small_molecule · active

1 trials project

NXC-201 CAR-T

Light Chain (AL) Amyloidosis

Phase 2 · mab · active

1 trials

Patents (2)

patent

US 11819571

Micelle constructs comprising curcumin

Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9833508

Cancer therapeutics

Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)